Other

Change at the top for Biogen after Alzheimer's drug flops

Biogen will replace its CEO and largely abandon marketing of its controversial Alzheimer's drug Aduhelm less than a year after the medication's launch triggered a backlash from experts, doctors and insurers.

Diseases, Conditions, Syndromes

COVIDSafe: Why the government should share what it knows

It's 18 days since the government launched its digital contact-tracing app COVIDSafe. The latest figure we have for downloads is 5.4 million, on May 8, about 29% of smartphone users aged 14 and over.

Health

Few countries offer a good place to die, researchers say

Among the most troubling scenes from the COVID-19 era are the images of patients dying in isolation, unable to be with loved ones during their final moments. But even before the pandemic, harrowing deaths were all too common ...

Health

Half of dentists say patients are high at dental appointments

As personal and medical marijuana use increases nationwide, the American Dental Association (ADA) suggests patients refrain from using marijuana before dental visits after a new survey finds more than half of dentists (52%) ...

page 3 from 31